- Home
- EDUC vs AIMD Comparison
EDUC vs AIMD Comparison
Compare EDUC & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDUC | AIMD |
|---|---|---|
| Founded | 1965 | 1984 |
| Country | United States | United States |
| Employees | N/A | 44 |
| Industry | Consumer Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7M | 9.8M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | EDUC | AIMD |
|---|---|---|
| Price | $1.32 | $1.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 19.2K | ★ 25.9K |
| Earning Date | 01-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.63 | N/A |
| Revenue | ★ $34,191,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.11 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.92 | $0.44 |
| 52 Week High | $1.84 | $4.50 |
Technical Indicators
Market Signals| Indicator | EDUC | AIMD |
|---|---|---|
| Relative Strength Index (RSI) | 44.39 | 44.96 |
| Support Level | $1.25 | $1.33 |
| Resistance Level | $1.35 | $1.73 |
| Average True Range (ATR) | 0.05 | 0.12 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 28.00 | 31.43 |
Price Performance
Historical ComparisonAbout EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.
About AIMD Ainos Inc.
Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.